2020
DOI: 10.1044/2020_persp-20-00094
|View full text |Cite
|
Sign up to set email alerts
|

Management of Patients Undergoing Radiation Treatment for Head and Neck Cancer During the COVID-19 Pandemic: Clinical Guidelines and Perspectives

Abstract: The COVID-19 pandemic has created challenges in providing health care throughout the United States. Despite limitations in in-person clinical care aimed at reducing transmission risk and preserving personal protective equipment, patients with head and neck cancer continue to undergo radiation-based treatment, resulting in the need for adapted care pathways. Speech-language pathologists play an instrumental role in the care of patients undergoing head and neck radiation prior to, during, and following the concl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 28 publications
0
2
0
Order By: Relevance
“…Although dysphagia was recognized as a prevalent sequela of COVID-19 [ 19 ] there were suddenly disruptions and barriers to providing usual dysphagia management for both COVID and non-COVID patients across every clinical domain. These barriers were created by infection control risks, particularly those associated with clinical and instrumental assessments being classified as aerosol generating procedures [ 14 , 20 22 ], as well as concerns for high-risk clinical populations [ 6 ] such as those in aged care [ 23 ] and people with head and neck cancer [HNC] [ 24 , 25 ]. The situation was then further exacerbated for some by other operational challenges, such as the need to ensure staff had adequate access to necessary personal protective equipment (PPE) [ 6 , 22 ], and in Australia a barium shortage further impacted the ability to conduct videofluoroscopic assessment (VFSS) services.…”
Section: Introductionmentioning
confidence: 99%
“…Although dysphagia was recognized as a prevalent sequela of COVID-19 [ 19 ] there were suddenly disruptions and barriers to providing usual dysphagia management for both COVID and non-COVID patients across every clinical domain. These barriers were created by infection control risks, particularly those associated with clinical and instrumental assessments being classified as aerosol generating procedures [ 14 , 20 22 ], as well as concerns for high-risk clinical populations [ 6 ] such as those in aged care [ 23 ] and people with head and neck cancer [HNC] [ 24 , 25 ]. The situation was then further exacerbated for some by other operational challenges, such as the need to ensure staff had adequate access to necessary personal protective equipment (PPE) [ 6 , 22 ], and in Australia a barium shortage further impacted the ability to conduct videofluoroscopic assessment (VFSS) services.…”
Section: Introductionmentioning
confidence: 99%
“…Since the onset of COVID-19, delivering CSEs via telepractice has been a model now recommended for use to minimize infection risk and enable the initial provision of dysphagia assessment services for patients with COVID-19 (Blumenfeld et al, 2020;Fong et al, 2020;Freeman-Sanderson et al, 2020;Ku et al, 2020;Malandraki et al, 2021;Mattei et al, 2020;Miles et al, 2021;Soldatova et al, 2020). However, although the last year has seen many more speech-language pathologists using this model to help manage patients and deliver services impacted by COVID, the original drivers for implementing CSEs via telepractice still remain.…”
mentioning
confidence: 99%